Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Condensed Consolidated Statements of Operations [Abstract]    
Sales $ 7,194,449 $ 12,636,638
Cost of sales 5,603,201 8,205,313
Gross profit 1,591,248 4,431,325
Operating expenses:    
Selling, general and administrative expenses 5,361,423 6,039,298
Amortization expense 559,375 559,375
Total operating expenses 5,920,798 6,598,673
Operating loss (4,329,550) (2,167,348)
Other income (expense):    
Investment and other income 48,628 48,165
Gain on sale of assets 2,700  
Fair value remeasurement of contingent forward contract   109,492
Fair value remeasurement of contingent value rights   19,179
Financing fees   (576,594)
Interest expense (133,449) (571,240)
Gain (loss) on debt extinguishment 332,412 (343,471)
Other income (expense), net 250,291 (1,314,469)
Net loss before income taxes (4,079,259) (3,481,817)
Income tax expense 11,355 14,615
Net loss $ (4,090,614) $ (3,496,432)
Basic net loss per share $ (1.20) $ (106.71)
Diluted net loss per share $ (1.20) $ (106.71)
Weighted Average Basic Shares Outstanding 3,406,616 32,766
Weighted Average Dilutive Shares Outstanding 3,406,616 32,766